While our immune correlation analyses and other studies in cancer suggest HILPDA may modulate NK cell dynamics, the HILPDA’s role in placental immunobiology requires direct experimental validation in pregnancy-specific contexts since the different immunosuppressive microenvironment may exist between placenta and tumors. The gene discussed is HILPDA; the disease is cancer.